AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca core EPS ($ per share) ($)
Form 6-K Quarterly & Form 20-F Core Financial Measures
Latest, Q2 2026
2.63
Period ended Jun 30, 2026
Change on a year earlier
+21.2%
2.17 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up core eps ($ per share)
Cite this data
StockData. (2026). AstraZeneca Core EPS ($ per share) ($), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core_eps
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.